Catalyst Wire Dossier Catalyst Wire Dossier

New anti-inflammatory substance

· LEO Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for New anti-inflammatory substance, covering 2024-10-26 to 2024-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis [Phase 1]

See pricing